MedPath

Kinesiotaping in Carpal Tunnel Syndrome

Not Applicable
Completed
Conditions
Carpal Tunnel Syndrome (CTS)
Registration Number
NCT06710041
Lead Sponsor
Karadeniz Technical University
Brief Summary

Objective: Kinesiotaping (KT) is a relatively new technique, which reduces the pressure on the median nerve by extending the transverse carpal ligament. The aim of this study was to evaluate the effectiveness of KT on Carpal tunnel syndrome (CTS) in a randomized, placebo-controlled manner.

Methods: Patients were randomly divided into three groups: Group 1 (KT plus tendon and nerve gliding exercises), Group 2 (sham-taping plus exercises) and Group 3 (exercises alone, control group). KT was applied 3 times with 5-day intervals throughout the study, with "neural technique" for median and ulnar nerves and "area correction technique" for carpal tunnel releasing. In the placebo group kinesiotapes were applied without stretching and proper position. Hand grip strength, VAS, Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), and Short Form-12 (SF-12) were measured as outcome parameters at the first visit, 3rd and 6th week.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • clicical diagnosis of mild and moderate CTS
  • having the CTS symptoms for at least 6 weeks
Exclusion Criteria
  • electrophysiological diagnosis of severe CTS,
  • thenar atrophy,
  • local corticosteroid injection or KT application or physical therapy treatment for CTS within the last 3 months,
  • patients with secondary metabolic causes for CTS (such as diabetes mellitus, pregnancy, rheumatoid arthritis, sarcoidosis, thyroid disease),
  • patients with other conditions that may cause neck and arm pain (cervical disc hernia, arthritis, epicondylitis, rotator cuff syndrome),
  • a history of fracture in the wrist,
  • previous CTS surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
pain levelFrom enrollment to the end of treatment at 3 weeks

pain level was assessed using visual analog scale.The minimum and maximum values were 0 and 10, and higher scores mean a better outcome.

Secondary Outcome Measures
NameTimeMethod
Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)From enrollment to the end of treatment at 6 weeks

The BCTQ is a disease specific questionnaire to evaluate the symptom severity and functional capacity. High scores indicate increased symtom severity and low functional capacity

Trial Locations

Locations (1)

Karadeniz Technical University

🇹🇷

Trabzon, Turkey

© Copyright 2025. All Rights Reserved by MedPath